Ivermectin is an antiparasitic medicine used to treat infections caused by certain worms and mites. In the United Kingdom, only one ivermectin product holds a UK marketing authorisation: Soolantra 10 mg/g cream, a topical treatment for the inflammatory spots of rosacea. Ivermectin tablets are not licensed in the UK — they can only be obtained on prescription as an unlicensed imported medicine, usually arranged by a hospital specialist for conditions such as strongyloidiasis, onchocerciasis, or crusted scabies.
Ivermectin belongs to a family of compounds called the avermectins. Its origin story is one of the more remarkable in modern pharmacology.
In the 1970s, the Japanese microbiologist Satoshi Ōmura was systematically screening soil bacteria for useful compounds. From a sample collected near a golf course in Kawana, Japan, he isolated a previously unknown organism, Streptomyces avermitilis. Working with William C. Campbell at Merck in the United States, the team found that the compounds it produced were devastatingly effective against parasitic worms. Chemical modification produced ivermectin — more potent and better tolerated than the parent compound.
The impact was extraordinary. Ivermectin became the backbone of mass drug administration programmes against river blindness (onchocerciasis) and lymphatic filariasis across sub-Saharan Africa and Latin America. Merck's Mectizan Donation Programme, launched in 1987, has distributed billions of treatments free of charge. In 2015, Ōmura and Campbell shared the Nobel Prize in Physiology or Medicine for the discovery, alongside Tu Youyou for artemisinin.
Ivermectin sits on the World Health Organization's Model List of Essential Medicines. It is, by any reasonable measure, one of the most consequential medicines of the twentieth century — which is precisely why the misinformation attached to it since 2020 has been so frustrating for the clinicians and researchers who use it properly.
Understanding the mechanism explains both why it works and where its risks lie.
Invertebrates — worms, mites, insects — have glutamate-gated chloride channels (GluCl) in their nerve and muscle cells. Ivermectin binds to these channels with high affinity and holds them open. Chloride ions flood in, the cell hyperpolarises, and the parasite is paralysed. It can no longer feed, move, or reproduce, and it dies. Ivermectin also interacts with GABA-gated chloride channels in some organisms, contributing to the same effect.
Mammals do not have glutamate-gated chloride channels of this type. We do have GABA-gated chloride channels — but they sit almost entirely within the central nervous system, behind the blood–brain barrier. A transporter protein called P-glycoprotein actively pumps ivermectin back out of the brain, keeping central nervous system concentrations very low.
This is the entire basis of ivermectin's safety margin in humans. It is also why two situations raise concern:
1. Very high doses, which can overwhelm P-glycoprotein transport.
2. Drugs or genetic variants that impair P-glycoprotein function, potentially allowing more ivermectin into the brain. (This is well documented in certain collie dog breeds with an MDR1 gene mutation, which is why ivermectin-containing veterinary products carry breed warnings.)
There is a third, separate mechanism relevant to the cream: in rosacea, ivermectin appears to work both by killing Demodex folliculorum mites — present in higher densities in rosacea-affected skin — and through a direct anti-inflammatory effect on the skin.
This is where UK readers often get confused, because most online information about ivermectin is written for a US audience where oral tablets are FDA-approved and widely stocked. The UK situation is different.
Soolantra 10 mg/g cream (ivermectin 1%) is licensed by the MHRA for the topical treatment of inflammatory lesions of papulopustular rosacea in adults. It is prescription-only. Local NHS formularies generally position it as an option for the spots and pustules of rosacea, with treatment reviewed after three months and typically not continued beyond four months in a single course.
It is worth being clear about what it does and does not treat: Soolantra targets the papules and pustules of rosacea. It is not a treatment for the persistent facial redness (erythema) or visible thread veins, which are managed differently — with topical brimonidine, laser or intense pulsed light therapy, and trigger avoidance.
Ivermectin tablets — sold in France and elsewhere as Stromectol 3 mg — have never held a UK marketing authorisation. The MHRA has confirmed that no manufacturer has applied for one.
This does not mean UK patients cannot access it. UK prescribers may lawfully prescribe an unlicensed medicine, or import one on a "named-patient" basis, where in their clinical judgement no suitable licensed alternative meets a patient's needs. In practice, oral ivermectin in the UK is usually:
Major centres such as the Hospital for Tropical Diseases in London and the Liverpool School of Tropical Medicine handle a large share of these cases.
|
Condition |
Parasite |
Role of ivermectin |
|---|---|---|
|
Strongyloidiasis |
Strongyloides stercoralis |
Treatment of choice internationally |
|
Onchocerciasis (river blindness) |
Onchocerca volvulus |
Kills microfilariae; repeated dosing needed |
|
Crusted (Norwegian) scabies |
Sarcoptes scabiei |
Combined with topical therapy; standard of care |
|
Classical scabies |
Sarcoptes scabiei |
Second-line in the UK; used in outbreaks or treatment failure |
|
Cutaneous larva migrans |
Animal hookworm larvae |
Highly effective, often single dose |
|
Lymphatic filariasis |
Wuchereria bancrofti and others |
Used in combination in mass drug administration |
|
Head lice |
Pediculus humanus capitis |
Topical or oral; off-label, used when standard treatments fail |
|
Demodicosis |
Demodex mites |
Topical, and orally in severe or immunosuppressed cases |
If you have been diagnosed with ordinary scabies, your GP will almost certainly prescribe permethrin 5% cream first, or malathion 0.5% aqueous liquid if permethrin is unsuitable. These are the UK first-line treatments. Ivermectin tablets tend to be reserved for crusted scabies, institutional outbreaks (care homes, for example), people who cannot apply topical treatment properly, or repeated treatment failure.
Recent UK supply problems with permethrin have increased interest in oral ivermectin, but the decision remains a clinical one made by your prescriber.
Read this section as background, not as instructions. Ivermectin dosing is weight-based and condition-specific, and getting it wrong matters. Follow the regimen your prescriber gives you.
Oral ivermectin is dosed in micrograms per kilogram of body weight, most commonly 200 micrograms/kg. For a 70 kg adult that works out at roughly 14 mg — around four or five 3 mg tablets. Doses are rounded to whole tablets, which is why tablet counts step up in bands rather than smoothly.
Approximate regimens used internationally:
|
Indication |
Typical regimen |
|---|---|
|
Strongyloidiasis |
200 mcg/kg as a single dose, sometimes repeated the following day or after two weeks |
|
Classical scabies |
200 mcg/kg, repeated after 7–14 days to catch newly hatched mites |
|
Crusted scabies |
Multiple doses (commonly days 1, 2, 8, 9 and 15, extended in severe cases) plus topical scabicide and keratolytics |
|
Onchocerciasis |
150 mcg/kg, repeated every 6–12 months while infection persists |
|
Cutaneous larva migrans |
200 mcg/kg as a single dose |
The repeat dose in scabies matters. Ivermectin kills mites but has limited effect on unhatched eggs. A second dose about a week later kills mites that hatched after the first.
The French Stromectol summary of product characteristics advises taking tablets with water on an empty stomach, at least one hour before food. Some clinicians deliberately give it with a fatty meal to increase absorption, since food substantially increases bioavailability — but that is a specialist judgement, not something to improvise.
Do not drink alcohol around the time of dosing. Alcohol may increase plasma concentrations and worsen dizziness.
Apply a pea-sized amount to each of five areas — forehead, chin, nose, and each cheek — then spread as a thin layer across the whole face, once daily, avoiding eyes, lips, and mucous membranes. Wash and dry the face first, and let it dry before applying make-up. Improvement is usually gradual over several weeks. If there has been no improvement after three months, treatment is normally stopped.
For the cream, apply the next dose as normal — do not double up. For a course of tablets, contact your prescriber for advice rather than guessing, particularly for multi-day regimens in crusted scabies.
Most people who take ivermectin at standard doses tolerate it well. Side effects fall into distinct categories.
These are usually mild and settle within a day or two:
Because dizziness and drowsiness are possible, do not drive or operate machinery until you know how it affects you.
The last of these catches people out. A transient flare early in treatment is recognised and usually settles. If it is severe or persists, speak to your prescriber.
When ivermectin is used to treat onchocerciasis, the dying microfilariae release antigens that trigger an inflammatory response — the Mazzotti reaction. Symptoms include fever, intense itching, rash, swollen and tender lymph nodes, joint pain, headache, and occasionally low blood pressure. It typically appears within a day or two of dosing and is more severe with heavier parasite loads.
This is a reaction to parasite death, not an allergy to the drug. It is anticipated and managed by treating clinicians, sometimes with antihistamines or corticosteroids.
The most important safety issue with ivermectin is severe encephalopathy in people co-infected with Loa loa (African eye worm), particularly those with very high microfilarial loads in the blood. Rapid killing of large numbers of microfilariae can cause a serious, occasionally fatal neurological reaction.
This is why anyone who has lived in or travelled extensively through the loiasis belt of Central and West Africa should be screened for Loa loa microfilaraemia before receiving ivermectin. It is one of several reasons oral ivermectin is a specialist medicine rather than a repeat-prescription item.
Seek urgent medical attention for:
Always give your prescriber and pharmacist a full list of your medicines, including supplements and anything bought over the counter.
This needs stating plainly. Do not take ivermectin products intended for animals.
Veterinary formulations — horse wormer pastes, cattle pour-on solutions, sheep drenches — are dosed for animals weighing several hundred kilograms. They are far more concentrated than human preparations, and they contain excipients that have never been assessed for human ingestion.
Reported consequences of taking veterinary ivermectin include vomiting, diarrhoea, low blood pressure, confusion, ataxia, hallucinations, seizures, and coma. Poison centres in several countries recorded sharp increases in ivermectin-related calls during 2021.
Equally, be cautious about unregulated online sellers. A number of websites advertise ivermectin tablets to UK customers "without prescription". Buying prescription medicines this way means no clinical oversight, no Loa loa screening, no interaction check — and no guarantee that the tablets contain what the label claims. Counterfeit and substandard products are a documented problem. If you buy from a UK online pharmacy, check that it is registered with the General Pharmaceutical Council and displays the appropriate registration logo.
For scabies, itching often continues for two to four weeks after successful treatment because it is driven by an immune reaction to mite debris, not live mites. Persistent itching does not automatically mean treatment failed. For rosacea, expect gradual improvement over four to twelve weeks with the cream.
Usually yes. A repeat dose after 7–14 days targets mites that hatched after the first dose. Your prescriber will confirm the schedule.
Safety data in pregnancy are limited, and treatment is generally deferred where clinically possible. If you are pregnant, planning pregnancy, or breastfeeding, discuss this with your clinician before starting
It is generally avoided in children weighing under 15 kg due to limited safety data. Above that weight, it is used in children under specialist supervision.
Topical ivermectin lotion is used for head lice in some countries, and oral ivermectin is used off-label in resistant cases. In the UK, first-line treatment is dimeticone or wet combing.
It is best avoided around the time of dosing, as alcohol may increase plasma levels and worsen dizziness.
Some laboratory and animal studies have explored ivermectin in oncology, but there is no robust clinical trial evidence supporting its use as a cancer treatment in humans. It should not be used for this purpose outside a clinical trial.
Please log in to add a comment.
Dr. James Lawson, a distinguished expert in pain management and pharmaceutical sciences. With over 20 years of medical experience, Dr. Lawson remains deeply committed to advancing safe and effective pain relief solutions. Though no longer in active clinical practice, his passion for healthcare and dedication to patient education continue to thrive. Through his extensive research and medical writing, Dr. Lawson supports our pharmacy’s mission by providing trusted insights on pain management, helping our valued customers make informed health decisions.